current publications

Current Publications

PUBLICATION LIST 2019
Cell death-inducing properties of selected dendrimers against different breast cancer and leukemia cell lines

Baecker D, Kapp T, Schumacher P, Gust R, Kircher B. Arch Pharm (Weinheim) 2020, 353(11):e2000209

Vaccination influenz(a)ing cancer-specific survival.

Wolf D, Pircher A. Int J Cancer 2020, Oct 14

Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives

Nagl L, Horvath L, Pircher A, Wolf D. Front Cell Dev Biol 2020, 8:766

The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis

Steiner N, Jöhrer K, Plewan S, Brunner-Veber A, Göbel G, Nachbaur D, Wolf D, Gunsilius E, Untergasser G. Cancers (Basel) 2020, 12(9):2341

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer

Steinbichler TB, Dudas J, Ingruber J, Glueckert R, Sprung S, Fleischer F, Cidlinsky N, Dejaco D, Kofler B, Giotakis AI, Skvortsova II, Riechelmann H. J Clin Med 2020, 9(7):2061

Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis

Neuwirt H, Bouchal J, Kharaishvili G, Ploner C, Jöhrer K, Pitterl F, Weber A, Klocker H, Eder IE. Cell Commun Signal 2020, 18(1):11

Synthesis and Characterization of Telmisartan-Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid Leukemia

Schoepf AM, Salcher S, Hohn V, Veider F, Obexer P, Gust R. ChemMedChem 2020, 15(12):1067-1077

Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells

Schoepf AM, Salcher S, Obexer P, Gust R. Eur J Med Chem 2020, 195:112258

Amide and ester derivatives of chlorido[4-carboxy-1,2-disalicylideneaminobenzene]iron(iii) as necroptosis and ferroptosis inducers Daniel Baecker 1 , Benjamin N Ma 1 , Jessica Sagasser 1 , Lukas Schultz 1 , Carina Hörschläger 1

Baecker D, Ma BN, Sagasser J, Schultz L, Hörschläger C, Weinreich M, Steiner L, Kircher B, Gust R. Dalton Trans 2020, https://pubmed.ncbi.nlm.nih.gov/32377663/

Editorial: Advances in Biological Understanding of Tumor Radiation Resistance

Skvortsova II, Span PN. Front Oncol 2020, 10:754

Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta-analysis

Park JH, Jeong GH, Lee KS, Lee KH, Suh JS, Eisenhut M, van der Vliet HJ, Kronbichler A, Stubbs B, Solmi M, Dragioti E, Koyanagi A, Shin JI, Gamerith G. Eur J Clin Invest 2020, 50(4):e13203

Uterine smooth muscle tumours of uncertain malignant potential: single-centre experience and review of the literature

Yordanov AD, Tantchev L, Vasileva P, Strashilov S, Vasileva-Slaveva M, Konsoulova A. PRZ Menopauzalny 2020, 19(1):30-34

The Role of Cancer Stem Cells in Radiation Resistance

Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. Front Oncol 2020, 10:164

Molecular heterogeneity in breast carcinoma cells with increased invasive capacities

Negro G, Aschenbrenner B, Brezar SK, Cemazar M, Coer A, Gasljevic G, Savic D, Sorokin M, Buzdin A, Callari M,Kvitsaridze I, Jewett A, Vasileve-Slaveva M, Ganswindt U, Skvortsova I, Skvortsov S. Radiol Oncol 2020, 54(1):103-118

Structure-Guided Identification of Black Cohosh ( Actaea racemosa) Triterpenoids with In Vitro Activity against Multiple Myeloma

Jöhrer K, Stuppner H, Greil R, Cicek SS. Molecules 2020, 25(4):766

Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78

Borjan B, Kern J, Steiner N, Gunsilius E, Wolf D, Untergasser G. Front Oncol 2020, 9:1530

Mucoepidermoid Carcinoma of the Uterine Cervix-Single-Center Study Over a 10-Year Period

Yordanov A, Karamanliev M, Tantchev L, Konsoulova A, Strashilov S, Vasileva-Slaveva M. Medicina (Kaunas) 2020, 56(1):37